Clinical Trials Logo

Obesity clinical trials

View clinical trials related to Obesity.

Filter by:

NCT ID: NCT03147209 Withdrawn - Obesity Clinical Trials

Pilot Intervention-Exercise for the Weight, Healthy Eating, and Exercise for the Long-Haul

PIE WHEEL
Start date: May 1, 2017
Phase: N/A
Study type: Interventional

Truckers face many unique challenges in their work that may adversely impact their health, including time constraints, sedentary job tasks, and a 'moving-workplace' environment with associated limitations to access healthy food and safe places to be physically active. These issues make it difficult to form and maintain healthy lifestyle habits and contribute to the high prevalence of injuries from both crashes and falls among truckers is supported by an increase in obesity among truckers with longer durations of employment. The investigators propose to develop and pilot test the Exercise Intervention of the Worksite Health, Eating and Exercising for the Long-haul (WHEEL)'s weight loss intervention. This pilot exercise intervention is aimed at achieving meaningful improvement in grip strength, balance, and gait over 6 weeks. The investigators will use pilot sample of 15 obese (BMI ≥ 30 kg/m2) truckers, documenting changes in these measures. Individualized assessments will be utilized. The investigators will aim to complete the following: 1. Evaluate the feasibility of the PIE WHEEL intervention for CMV drivers will result in greater strength comparing baseline with 6 week outcomes. 1. Determine the extent to which drivers will participate in PIE WHEEL 2. Determine the extent of change in strength, balance and gait realized by PIE WHEEL participation 2. Evaluate safety events (crashes, near misses, falls) in the week prior to PIE WHEEL and the final week of PIE WHEEL a. Solicit driver perceptions of their own safety of ingress and egress related to PIE WHEEL participation

NCT ID: NCT03075345 Withdrawn - Clinical trials for Obesity, Acceptance and Commitment Therapy, Weight Management Service

Acceptance and Commitment Therapy in the Treatment of Obesity: Pilot.

Start date: May 2017
Phase: N/A
Study type: Interventional

Obesity is an 'epidemic' within the UK. Individuals living with obseity are at risk of developing cancer, heart problems and dieing. Furthermore, obesity impacts on psychological wellbeing via lowered self-efficacy, self-esteem, body image and overall quality of life (QoL). A pilot randomised controlled trial (RCT) is proposed to investigate the additional benefit of a psychological intervention alongside treatment as usual (TAU) in a weight management service. Patients routinely attending an outpatient clinic will be randomised into TAU with or without additional acceptance and commitment Therapy (ACT) group based-input and their outcomes monitored over time.

NCT ID: NCT03042897 Withdrawn - Obesity Clinical Trials

Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer

Start date: September 8, 2017
Phase: N/A
Study type: Interventional

This pilot clinical trial studies exercise and diet intervention in promoting weight loss in obese patients with stage I endometrial cancer. Exercise and diet may cause weight loss and minimize the risk of gynecologic surgery related to being overweight in patients with endometrial cancer.

NCT ID: NCT03001583 Withdrawn - Obesity Clinical Trials

Clinical Trial Comparing Two Health Education Programs for Obese Patients (HEPO-TRIAL)

Start date: October 30, 2019
Phase: N/A
Study type: Interventional

Clinical trial comparing two health education programs for obese patients in order to achieve a substantial and beneficial weight loss, using mediterranean diet. Patients will be allocated to two groups, one will receive education in diet and lifestyle, and the other one the same plus cooking lessons. The intervention period is for 6 months with monthly visits and phone and email contacts in between. An extension observation period of two years is also planned with 6 months contacts in our clinic, also with phone and email contact available.

NCT ID: NCT02999945 Withdrawn - Diabetes Clinical Trials

Optimal Growth of Preterm Infants With Growth Restriction

OPTIGROW
Start date: March 2019
Phase: N/A
Study type: Interventional

In this prospective randomized controlled multi center trial the investigators stratify "Very Low Birthweight " (VLBW)-infants with growth retardation in small for gestational age (SGA) or intrauterine growth restricted (IUGR) - infants and aim to investigate the impact of a nutritional management with enhanced nutrients from discharge up to the 52nd week of postconceptional age on growth, body composition, metabolic programming, metabolomics, microbiome and long term neurodevelopmental outcome. In this study, the investigators will evaluate the difference in metabolic profiles of SGA and IUGR preterm infants. The investigators will further longitudinally assess, how different nutritional interventions affect the altered pathways in the first year of life and identify, in combination with data available from metabolic markers, microbiome and breast milk analysis, potential pathways resulting in increased disease risk later in life.

NCT ID: NCT02994186 Withdrawn - Obesity Clinical Trials

Examination of Cognitive Function in Obesity and Following Weight Loss

Start date: July 1, 2018
Phase:
Study type: Observational

Bariatric surgery is the most effective, long-term treatment for morbid obesity, and consistent with previous findings, individuals who lose significant weight after surgery also have improved cognition or "brain function". The mechanisms behind these cognitive improvements are currently unknown, but are the focus of much research effort. The goal of this pilot study is to thoroughly describe these changes in surgical versus medical weight loss patients over time in a repeated measures fashion.

NCT ID: NCT02981160 Withdrawn - Obesity Clinical Trials

Validation of a Personal Breath Analyzer for Diet and Energy Expenditure Assessment and Management

Breezing
Start date: December 2016
Phase: N/A
Study type: Interventional

The purpose of the research is to determine energy expenditure rates and diet and/ physical activity metabolic features of an individual using current state technologies and a new technology created at the Center for Bioelectronics and Biosensors at ASU. This is a pilot study which intent is to validate this device for use in the weight loss patient population. This study will involve research of metabolic physiological parameters that are measured through the breath of the individuals, together with other physical parameters (weight, height, date of birth, fat and lean body composition via bio-impedance, heart rate, blood pressure, and breathing rate) assessed in the clinic, and a questionnaire about diary physical activities. The study will involve withdrawn of breath samples at resting conditions, and under diets or physical activities regimes. This instrument will assist our patients in terms of tailoring their diet/nutrition through their weight loss journey prior and after surgery. As a new technology, it will be an excellent tool for compliance assessment and engagement with the Weight Loss Program as well as for long term follow up.

NCT ID: NCT02949687 Withdrawn - Obesity Clinical Trials

Surgical Treatment in Diabetic Patients With Grade 1 Obesity

Start date: September 20, 2016
Phase: N/A
Study type: Interventional

Surgical Treatment in Diabetic Patients With Grade 1 Obesity

NCT ID: NCT02932202 Withdrawn - Obesity Clinical Trials

Women Eating With Interactive Tracking to Gain Healthily Through Term Pregnancy Trial

WEIGHT
Start date: July 8, 2016
Phase: N/A
Study type: Interventional

Obesity and excessive weight gain in pregnancy have significant associated maternal and fetal complications including gestational diabetes, large for gestational age infants, birth trauma, and stillbirth. The standard of care places the responsibility on the providers during prenatal visits to remind patients of their weight gain goals and provide appropriate counseling. The objective of this study is to evaluate a sustainable medical student-assisted longitudinal program of nutritional counseling and web based nutrition tracking for pregnant women on excessive weight gain during pregnancy and the effects on diet choices and fetal and maternal complications.

NCT ID: NCT02920190 Withdrawn - Obesity Clinical Trials

Antigen-Lipid-Driven Monoclonal Gammopathies Targeting Epicardial Fat

Start date: September 1, 2020
Phase: Phase 4
Study type: Interventional

The purpose of this research study is to learn about the effect of Liraglutide (Victoza) on the fat of the heart and some fat cells in blood.